Bullous pemphigoid after SARS‐CoV‐2 vaccination: spike‐protein‐directed immunofluorescence confocal microscopy and T‐cell‐receptor studies

T. Gambichler,N. Hamdani,H. Budde,M. Sieme,M. Skrygan,L. Scholl,H. Dickel,B. Behle,N. Ganjuur,C. Scheel,N. Abu Rached,L. Ocker,R. Stranzenbach,M. Doerler,L. Pfeiffer,J.C. Becker
DOI: https://doi.org/10.1111/bjd.20890
IF: 11.113
2022-01-20
British Journal of Dermatology
Abstract:Abstract Dear Editor, Growing evidence suggests that SARS‐CoV‐2 vaccination is associated with a variety of cutaneous reactions, also including autoimmune‐mediated conditions such as autoimmune blistering diseases such as bullous pemphigoid (BP).1,2 We report new‐onset BP in two patients following the first SARS‐CoV‐2 vaccination.
dermatology
What problem does this paper attempt to address?